Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
15-Jun-2011Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free SurvivalDai, W; Teodoridis, JM; Zeller, C; Graham, J; Hersey, J, et al
18-Mar-2014A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerGlasspool, RM; Brown, R; Gore, ME; Rustin, GJS; McNeish, IA, et al
1-Oct-2017RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancerHoppe, MM; Tan, DSP; Lim, DGZ; Karnezis, A; Huntsman, D, et al
23-Sep-2016Platinum-based chemotherapy induces methylation changes in blood DNA associated with overall survival in ovarian cancer patientsFlanagan, JM; Wilson, A; Koo, C; Masrour, N; Gallon, J, et al
20-May-2015Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).Brown, R; Timms, K; Paul, J; Hughes, E; El-Bahrawy, M, et al
27-Mar-2013Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31Permuth-Wey, J; Lawrenson, K; Shen, HC; Velkova, A; Tyrer, JP, et al
27-May-2011Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association ConsortiumAmankwah, EK; Wang, Q; Schildkraut, JM; Tsai, Y-Y; Ramus, SJ, et al
19-Sep-2010Common variants at 19p13 are associated with susceptibility to ovarian cancerBolton, KL; Tyrer, J; Song, H; Ramus, SJ; Notaridou, M, et al
27-Mar-2013GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerPharoah, PDP; Tsai, Y-Y; Ramus, SJ; Phelan, CM; Goode, EL, et al
1-Jul-2018Biomarker assessment of HR deficiency, tumor BRCA1/2 mutations and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapyStronach, EA; Paul, J; Timms, KM; Hughes, E; Brown, K, et al